Iron bound to a porphyrin ring in the heme molecule, found exclusively in animal tissue hemoglobin and myoglobin. Absorbed via HCP1 (heme carrier protein 1) with 15-35% bioavailability, independent of dietary enhancers or inhibitors that regulate Non-heme iron absorption. Clinical relevance centers on balancing deficiency correction against pro-oxidant risks at high intake levels.
Imagine heme iron as a VIP guest arriving at an exclusive club entrance. While regular iron (non-heme) has to queue at the main entrance where bouncers (phytates, tannins) might turn it away or where a helpful friend (Vitamin C) might get it in, heme iron walks straight through a private side door (HCP1) with guaranteed entry. Once inside the club (enterocyte), heme iron's fancy outfit (the porphyrin ring) gets removed by coat-check (heme oxygenase), releasing the iron itself. The club can either store this iron in the cloakroom (Ferritin) or send it upstairs to the main party (bloodstream) via the export elevator (Ferroportin). The downside: too many VIPs showing up creates chaos—excess heme iron is like hundreds of wealthy troublemakers starting fights (generating Oxidative Stress through the Fenton reaction), damaging the club's infrastructure and increasing the risk of serious problems like cardiovascular disease and Cancer.
graph TD
A[Heme iron in meat] -->|Digestion| B[Intact heme molecule in intestinal lumen]
B -->|HCP1/SLC46A1| C[Heme enters enterocyte]
C -->|Heme oxygenase-1 HO-1| D["Fe²⁺ released + biliverdin"]
D -->|Storage| E[Ferritin]
D -->|Export| F[Ferroportin FPN1]
F -->|Hepcidin regulation| G[Transferrin in blood]
H[High body iron stores] -->|Increases| I[Hepcidin synthesis in liver]
I -->|Degrades| F
J[Excess heme in lumen] -->|Pro-oxidant| K[Lipid peroxidation]
K -->|N-nitroso compounds| L[DNA damage in colonocytes]
Enterocyte Entry:
- Heme carrier protein 1 (HCP1/SLC46A1) on apical membrane transports intact metalloporphyrin
- Transport independent of DMT1 (divalent metal transporter 1) used for non-heme iron
- pH-dependent but not influenced by gastric acid, Vitamin C, or phytates
Intracellular Processing:
- Heme oxygenase-1 (HO-1) cleaves porphyrin ring → releases Fe²⁺ + biliverdin + CO
- Free Fe²⁺ enters labile iron pool (LIP) within enterocyte
- Excess iron binds to Ferritin (24-subunit storage complex)
- Ferroportin (FPN1) exports Fe²⁺ across basolateral membrane
- Hephaestin or ceruloplasmin oxidizes Fe²⁺ → Fe³⁺ for binding to transferrin
Systemic Regulation:
- Hepcidin (liver-derived peptide hormone) binds ferroportin → internalization and degradation
- High iron stores → increased hepcidin → reduced absorption and cellular iron export
- Inflammation (IL-6) increases hepcidin → Inflammatory anaemia
- Erythropoietic demand suppresses hepcidin (EPO, erythroferrone signaling)
Pro-oxidant Effects at High Intake:
- Fenton reaction: Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻
- Hydroxyl radical (OH•) damages DNA, lipids, proteins
- Heme in colon catalyzes formation of lipid peroxidation products (4-HNE, MDA)
- N-nitroso compound formation from heme iron + amines → mutagenic compounds
- Cytotoxic heme → colonocyte death → compensatory hyperproliferation → Cancer risk
Deficiency Correction:
Heme iron is the most effective dietary intervention for Iron deficiency and Iron deficiency anemia due to superior bioavailability (15-35% vs 2-20% for non-heme). Particularly valuable for patients with:
- Inflammatory bowel disease where inflammation impairs non-heme absorption
- Vegetarian/vegan patients transitioning or with refractory deficiency
- Pregnancy when demands exceed plant-based iron absorption capacity
- Athletes with increased requirements and hepcidin elevation from training
Cardiovascular and Cancer Risk:
High heme iron intake (>1.5 mg/day) associates with:
- 18% increased colorectal Cancer risk per 1 mg/day increment
- Increased myocardial infarction risk (meta-analysis OR 1.57, 95% CI 1.28-1.94)
- Elevated Oxidative Stress markers (F2-isoprostanes, oxidized LDL)
- Type 2 Diabetes risk through pancreatic β-cell oxidative damage
cPNI Integration:
From a 5 plus 2 metamodel perspective, excessive heme iron represents evolutionary mismatch—hunter-gatherer red meat consumption averaged 50-100g/day with high physical activity (oxidant buffering), whereas modern intake often exceeds 200g/day with sedentary behavior. The Selfish Immune System responds to excess iron by increasing hepcidin, creating Inflammatory anaemia paradox—high ferritin with functional deficiency.
Intervention Strategy:
- Favor fish (1.0 mg heme iron/100g) and poultry (0.7 mg/100g) over red meat (2-3 mg/100g)
- Limit red meat to 1-2x/week; prioritize grass-fed sources with higher Omega-3 (anti-inflammatory buffer)
- Combine with Polyphenols (EGCG, quercetin) to chelate excess iron post-absorption
- For deficiency: 100-150g red meat 3x/week provides ~5-7 mg heme iron (sufficient to restore without excess)
- Monitor Ferritin (target 50-100 μg/L) and transferrin saturation (<45%)
Clinical Biomarkers:
- Serum ferritin: <30 μg/L = deficiency; >300 μg/L = overload risk
- Transferrin saturation: <20% = deficiency; >45% = accumulation
- High-sensitivity CRP: >3 mg/L may falsely elevate ferritin (acute phase protein)
- Soluble transferrin receptor (sTfR): differentiates true iron deficiency from Inflammation
- Bioavailability: 15-35% (3-10× higher than non-heme iron sources)
- Primary sources: Red meat (2-3 mg/100g), poultry (0.7 mg/100g), fish (1.0 mg/100g)
- Absorption mechanism: HCP1/SLC46A1 transporter, independent of stomach acid or vitamin C
- Cancer threshold: >1.5 mg heme iron/day associated with 18% increased colorectal cancer risk per mg increment
- Evolutionary context: Hunter-gatherer intake ~50-100g red meat/day vs modern average 200g+/day
- Regulatory hormone: Hepcidin (liver-derived) degrades ferroportin to limit absorption when stores are adequate
- Oxidative pathway: Fenton reaction (Fe²⁺ + H₂O₂ → OH• radical) drives lipid peroxidation and DNA damage
- Inflammatory interaction: IL-6 increases hepcidin → Inflammatory anaemia despite adequate iron stores
- Pregnancy needs: 27 mg total iron/day (heme iron improves bioavailability without needing higher doses)
- Clinical target ferritin: 50-100 μg/L optimal; <30 μg/L deficiency; >300 μg/L overload concern
- Non-heme iron — absorbed via DMT1 with 2-20% bioavailability; requires gastric acid and vitamin C enhancement
- Ferritin — intracellular storage protein for absorbed iron; serum ferritin reflects iron stores but elevated by inflammation
- Ferroportin — sole cellular iron exporter; degraded by hepcidin to regulate systemic iron homeostasis
- Hepcidin — master iron regulatory hormone; increased by IL-6 in inflammation, causing functional iron deficiency
- Iron deficiency — heme iron most effective correction strategy; 100-150g red meat 3x/week provides adequate repletion
- Inflammatory anaemia — paradoxical anemia with elevated ferritin due to hepcidin blocking iron release from stores
- Vitamin C — enhances non-heme iron absorption but has minimal effect on heme iron uptake
- Oxidative Stress — excess heme iron generates hydroxyl radicals via Fenton reaction, damaging DNA and lipids
- Red meat — primary dietary heme iron source; associations with CVD and cancer partially mediated by iron content
- Cancer — colorectal cancer risk increases 18% per 1 mg/day heme iron; mechanism involves N-nitroso compounds and lipid peroxidation
- Inflammation — IL-6 upregulates hepcidin, creating functional iron deficiency despite adequate stores
- Type 2 Diabetes — high heme iron intake associated with pancreatic β-cell oxidative damage and insulin resistance
- Inflammatory bowel disease — heme iron absorption advantage when intestinal inflammation impairs non-heme uptake
- Polyphenols — EGCG, quercetin chelate excess iron and reduce oxidative damage from heme iron
- Omega-3 — anti-inflammatory buffering in grass-fed red meat reduces heme iron oxidative effects
- HCP1 — specific transporter (SLC46A1) mediating heme iron enterocyte uptake independent of DMT1 pathway
- DMT1 — divalent metal transporter for non-heme iron; not involved in heme iron absorption
- Transferrin — plasma iron transport protein; carries Fe³⁺ released from ferroportin to tissues
- EPO — erythropoietin suppresses hepcidin when red blood cell production demands increase iron availability
- Bifidobacteria — gut bacteria that produce short-chain fatty acids may reduce heme iron-induced colonic damage through anti-inflammatory effects
(no context found)